John R. Kelsoe

John R. Kelsoe

Auto-generated profile, based on publicly available information

John R. Kelsoe

Department of Psychiatry, University of California, San Diego, La Jolla, USA

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2019 in Nature Genetics
Verified
Journal Article
Open access
PDF file
ECeQTLGen Consortium
eQTLGen Consortium
ESEli A. Stahl
Eli A. Stahl
BCBIOS Consortium
BIOS Consortium
TCthe Bipolar Disorder Working Group of the Psychiatric Genomics Consortium
the Bipolar Disorder Working Group of the Psychiatric Genomics Consortium
GBGerome Breen
Gerome Breen
PSPamela Sklar
Pamela Sklar
Bipolar disorder is a highly heritable psychiatric disorder. We performed a genome-wide association study (GWAS) including 20,352 cases and 31,358 controls of European descent, with follow-up analysis of 822 variants with P < 1 × 10−4 in an additional 9,412 cases and 137,760 controls. Eight of the 19 variants that were genome-wide significant (P < 5 × 10−8) in the discovery GWAS were not genome-wide significant in the combined analysis, consistent with small effect sizes and limited power but also with genetic heterogeneity. In the combined analysis, 30 loci were genome-wide significant, including 20 newly identified loci. The significant loci contain genes encoding ion channels, neurotransmitter transporters and synaptic components. Pathway analysis revealed nine significantly enriched gene sets, including regulation of insulin secretion and endocannabinoid signaling. Bipolar I disorder is strongly genetically correlated with schizophrenia, driven by psychosis, whereas bipolar II disorder is more strongly correlated with major depressive disorder. These findings address key clinical questions and provide potential biological mechanisms for bipolar disorder.

28 October 2015 in Nature
Verified
Journal Article
Closed access
PDF file
TSThe Pharmacogenomics of Bipolar Disorder Study
The Pharmacogenomics of Bipolar Disorder Study
JMJerome Mertens
Jerome Mertens
QWQiu-Wen Wang
Qiu-Wen Wang
YKYongsung Kim
Yongsung Kim
DYDiana X. Yu
Diana X. Yu
JYJun Yao
Jun Yao

19 August 2019 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
JLJia Jia Liu
Jia Jia Liu
YWYa Bin Wei
Ya Bin Wei
RSRebecca Strawbridge
Rebecca Strawbridge
Yanping BaoYanping Bao
Yanping Bao
SCSuhua Chang
Suhua Chang
LLLin Lu
Lin Lu

27 March 2006 in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
Verified
Journal Article
Closed access
PDF file
CNCaroline Nievergelt
Caroline Nievergelt
DKDaniel F. Kripke
Daniel F. Kripke
TBThomas B. Barrett
Thomas B. Barrett
EBElyssa Burg
Elyssa Burg
RRRonald A. Remick
Ronald A. Remick
JKJohn R. Kelsoe
John R. Kelsoe

23 January 2009 in Journal of Circadian Rhythms
Verified
Journal Article
Open access
PDF file
DKDaniel F Kripke
Daniel F Kripke
CNCaroline Nievergelt
Caroline Nievergelt
EJEj Joo
Ej Joo
TSTatyana Shekhtman
Tatyana Shekhtman
JKJohn R Kelsoe
John R Kelsoe
Clinical symptoms of affective disorders, their response to light treatment, and sensitivity to other circadian interventions indicate that the circadian system has a role in mood disorders. Possibly the mechanisms involve circadian seasonal and photoperiodic mechanisms. Since genetic susceptibilities contribute a strong component to affective disorders, we explored whether circadian gene polymorphisms were associated with affective disorders in four complementary studies.

17 February 2015 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
SASeth A. Ament
Seth A. Ament
SSSzabolcs Szelinger
Szabolcs Szelinger
GGGwênlyn Glusman
Gwênlyn Glusman
JAJustin Ashworth
Justin Ashworth
LHLiping Hou
Liping Hou
DQDanjuma Quarless
Danjuma Quarless
We sequenced the genomes of 200 individuals from 41 families multiply affected with bipolar disorder (BD) to identify contributions of rare variants to genetic risk. We initially focused on 3,087 candidate genes with known synaptic functions or prior evidence from genome-wide association studies. BD pedigrees had an increased burden of rare variants in genes encoding neuronal ion channels, including subunits of GABAA receptors and voltage-gated calcium channels. Four uncommon coding and regulatory variants also showed significant association, including a missense variant in GABRA6. Targeted sequencing of 26 of these candidate genes in an additional 3,014 cases and 1,717 controls confirmed rare variant associations in ANK3, CACNA1B, CACNA1C, CACNA1D, CACNG2, CAMK2A, and NGF. Variants in promoters and 5′ and 3′ UTRs contributed more strongly than coding variants to risk for BD, both in pedigrees and in the case-control cohort. The genes and pathways identified in this study regulate diverse aspects of neuronal excitability. We conclude that rare variants in neuronal excitability genes contribute to risk for BD. Significance Bipolar disorder (BD) is a common, severe, and recurrent psychiatric disorder with no known cure and substantial morbidity and mortality. Heritable causes contribute up to 80% of the lifetime risk for BD. Common genetic variation explains ∼25% of this heritable risk. Rare genetic variants may explain additional risk. We identified contributions of rare variants to BD by sequencing the genomes of 200 individuals from 41 families with BD. The two main findings of this study were as follows: rare risk variants for BD were enriched in genes and pathways that regulate diverse aspects of neuronal excitability; and most of these risk variants were noncoding with predicted regulatory functions. These results highlight specific hypotheses for future research and potential therapeutic targets.